Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


19.09.2022

1 Am Heart J
4 Am J Cardiol
1 Am J Emerg Med
4 Can J Cardiol
9 Catheter Cardiovasc Interv
1 Circulation
2 Clin Cardiol
2 Curr Opin Cardiol
3 Dtsch Med Wochenschr
2 Eur Heart J
3 Heart
3 Hypertension
3 Int J Cardiol
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
2 JAMA
2 Lancet
2 Mol Cell Biochem
2 N Engl J Med
3 PLoS One
1 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    PubMed         Abstract available


    Am J Cardiol

  2. BHATIA K, Jain V, Hendrickson MJ, Aggarwal D, et al
    Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock.
    Am J Cardiol. 2022;181:94-101.
    PubMed         Abstract available

  3. LOPEZ PD, Bhatia K, Bohra C, Mahmood K, et al
    Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart Failure.
    Am J Cardiol. 2022 Aug 11. pii: S0002-9149(22)00750.
    PubMed         Abstract available

  4. GONCALVES-RAMIREZ LR, Amat-Santos IJ, Altisent OA, Gutierrez H, et al
    Structural and Functional Evaluation of Coronary Arteries Treated With ABSORB Bioresorbable Vascular Scaffold at 5-Year Follow-Up.
    Am J Cardiol. 2022 Sep 6. pii: S0002-9149(22)00846.
    PubMed         Abstract available

  5. PICCOLO R, Bonaa KH, Efthimiou O, Varenne O, et al
    Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes.
    Am J Cardiol. 2022 Sep 6. pii: S0002-9149(22)00847.
    PubMed         Abstract available


    Am J Emerg Med

  6. REKIK N, Bouzid S, Abdelhedi A, Bouzid K, et al
    Post-traumatic symptoms in patients with acute coronary syndrome: Maybe an outcome predictor after the ED visit!
    Am J Emerg Med. 2022;61:117-119.
    PubMed         Abstract available


    Can J Cardiol

  7. GAGNON LR, Sadasivan C, Perera K, Oudit GY, et al
    Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology, and Management.
    Can J Cardiol. 2022;38:1331-1341.
    PubMed         Abstract available

  8. MIDDLEKAUFF HR, Cooper ZD, Strauss SB
    Drugs of Misuse: Focus on Vascular Dysfunction.
    Can J Cardiol. 2022 Apr 21. pii: S0828-282X(22)00261.
    PubMed         Abstract available

  9. D'ENTREMONT MA, Couture EL, Connelly K, Walling A, et al
    Management of the Master Endurance Athlete With Stable Coronary Artery Disease.
    Can J Cardiol. 2022;38:1450-1453.
    PubMed        

  10. LUCYK SN
    Acute Cardiovascular Toxicity of Cocaine.
    Can J Cardiol. 2022;38:1384-1394.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  11. ALTSTIDL JM, Achenbach S, Marwan M, Trobs M, et al
    Comparison of adenosine-independent pressure indices to fractional flow reserve in stent-jailed bifurcation side branches.
    Catheter Cardiovasc Interv. 2022;100:369-377.
    PubMed         Abstract available

  12. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    PubMed         Abstract available

  13. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    PubMed         Abstract available

  14. OKUYA Y, Gohil K, Moussa ID
    Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jul 5. doi: 10.1002/ccd.30304.
    PubMed         Abstract available

  15. TRIANTAFYLLIS AS, van Nunen LX, Lesizza P, Pagourelias ED, et al
    Angiographic predictors of aberrant circumflex artery during cardiac catheterization.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30322.
    PubMed         Abstract available

  16. VON LEWINSKI D, Herold L, Stoffel C, Patzold S, et al
    PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
    Catheter Cardiovasc Interv. 2022;100:319-327.
    PubMed         Abstract available

  17. BUTMAN SM
    Variability in healthcare delivery: It is never a good thing.
    Catheter Cardiovasc Interv. 2022;100:317-318.
    PubMed         Abstract available

  18. MUSUMECI G, Civera S
    When not to treat could be the best option.
    Catheter Cardiovasc Interv. 2022;100:338-339.
    PubMed         Abstract available

  19. SETO AH, Long VJ
    Should doctors replace machines in prehospital electrocardiogram interpretation?
    Catheter Cardiovasc Interv. 2022;100:304-305.
    PubMed        


    Circulation

  20. SHAH AM, Claggett B, Prasad N, Li G, et al
    Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
    Circulation. 2022 Sep 9:101161CIRCULATIONAHA122059210.
    PubMed         Abstract available


    Clin Cardiol

  21. YANG Y, Hong Y, Yang W, Zheng Z, et al
    Association of lipoprotein(a) with aortic dissection.
    Clin Cardiol. 2022;45:908-912.
    PubMed         Abstract available

  22. MANIAR Y, Blumenthal RS, Alfaddagh A
    The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.
    Clin Cardiol. 2022 Sep 10. doi: 10.1002/clc.23918.
    PubMed         Abstract available


    Curr Opin Cardiol

  23. UEKI Y, Raber L
    Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention.
    Curr Opin Cardiol. 2022 Sep 13. pii: 00001573-990000000-00024.
    PubMed         Abstract available

  24. DEL BUONO MG, La Vecchia G, Rinaldi R, Sanna T, et al
    Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine.
    Curr Opin Cardiol. 2022 Sep 13. pii: 00001573-990000000-00022.
    PubMed         Abstract available


    Dtsch Med Wochenschr

  25. RUSS M
    [Short- and long-term follow-up care in patients with infarction-related cardiogenic shock].
    Dtsch Med Wochenschr. 2022;147:1187-1194.
    PubMed         Abstract available

  26. BRUNO RR, Kelm M, Jung C
    [Pharmaceutical therapy of infarct-related cardiogenic shock].
    Dtsch Med Wochenschr. 2022;147:1173-1182.
    PubMed         Abstract available

  27. JANSSENS U
    [Infarct-related cardiogenic shock].
    Dtsch Med Wochenschr. 2022;147:1157-1158.
    PubMed        


    Eur Heart J

  28. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed         Abstract available

  29. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed        


    Heart

  30. CHANNON KM, Newby DE, Nicol ED, Deanfield J, et al
    Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat.
    Heart. 2022 Jan 12. pii: heartjnl-2021-320265. doi: 10.1136/heartjnl-2021-320265
    PubMed         Abstract available

  31. GARCIA-GUIMARAES M, Masotti M, Sanz-Ruiz R, Macaya F, et al
    Clinical outcomes in spontaneous coronary artery dissection.
    Heart. 2022;108:1530-1538.
    PubMed         Abstract available

  32. GRAHAM RM
    Adverse events after spontaneous coronary artery dissection.
    Heart. 2022;108:1506-1507.
    PubMed        


    Hypertension

  33. HUANG Z, Chen Z, Wang X, Ding X, et al
    Association of Cardiovascular Health Score Trajectory With Incident Myocardial Infarction in Hypertensive Patients.
    Hypertension. 2022 Sep 9:101161HYPERTENSIONAHA12219633.
    PubMed         Abstract available

  34. HAMZAOUI M, Groussard D, Nezam D, Djerada Z, et al
    Endothelium-Specific Deficiency of Polycystin-1 Promotes Hypertension and Cardiovascular Disorders.
    Hypertension. 2022 Sep 12:101161HYPERTENSIONAHA12219057.
    PubMed         Abstract available

  35. KATUNARIC B, SenthilKumar G, Schulz ME, De Oliveira N, et al
    S1P (Sphingosine-1-Phosphate)-Induced Vasodilation in Human Resistance Arterioles During Health and Disease.
    Hypertension. 2022;79:2250-2261.
    PubMed         Abstract available


    Int J Cardiol

  36. TORGUSON R, Mintz GS, Case BC, Di Mario C, et al
    Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
    Int J Cardiol. 2022;366:32-34.
    PubMed         Abstract available

  37. SHARMA A, Gupta I, Venkatesh U, Singh AK, et al
    E-cigarettes and myocardial infarction: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Sep 7. pii: S0167-5273(22)01315.
    PubMed         Abstract available

  38. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The perfect-CR study.
    Int J Cardiol. 2022 Sep 8. pii: S0167-5273(22)01322.
    PubMed         Abstract available


    J Am Coll Cardiol

  39. SEMSARIAN C, Gray B, Haugaa KH, Lampert R, et al
    Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases: JACC Focus Seminar 3/4.
    J Am Coll Cardiol. 2022 Aug 19. pii: S0735-1097(22)05663.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  40. MASTER YW, Master QZ, Master HC, Master ZW, et al
    Effects of recombinant human brain natriuretic peptide on atrial fibrillation after coronary artery bypass grafting.
    J Cardiovasc Pharmacol. 2022 Sep 9. pii: 00005344-990000000-00114.
    PubMed         Abstract available


    JAMA

  41. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
    Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
    JAMA. 2022;328:951-962.
    PubMed         Abstract available

  42. FEINSTEIN MJ
    HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
    JAMA. 2022;328:931-932.
    PubMed        


    Lancet

  43. WALLI-ATTAEI M, Rosengren A, Rangarajan S, Breet Y, et al
    Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study.
    Lancet. 2022;400:811-821.
    PubMed         Abstract available

  44. MANFRINI O, Bugiardini R
    Behavioural risk factors and cardiovascular disease: are women at higher risk?
    Lancet. 2022;400:788-789.
    PubMed        


    Mol Cell Biochem

  45. JIANG T, You H, You D, Zhang L, et al
    Retraction Note: A miR1275 mimic protects myocardiocyte apoptosis by regulating the Wnt/NFkappaB pathway in a rat model of myocardial ischemia-reperfusioninduced myocardial injury.
    Mol Cell Biochem. 2022 Sep 13. pii: 10.1007/s11010-022-04547.
    PubMed        

  46. BORA VR, Gohel D, Singh R, Patel BM, et al
    Evaluation of selected antidiabetics in cardiovascular complications associated with cancer cachexia.
    Mol Cell Biochem. 2022 Sep 13. pii: 10.1007/s11010-022-04552.
    PubMed         Abstract available


    N Engl J Med

  47. PARK DW, Kang DY, Ahn JM, Yun SC, et al
    Routine Functional Testing or Standard Care in High-Risk Patients after PCI.
    N Engl J Med. 2022;387:905-915.
    PubMed         Abstract available

  48. TAMIS-HOLLAND JE
    Surveillance Stress Testing "POST-PCI" - A Future Class III Recommendation?
    N Engl J Med. 2022;387:941-942.
    PubMed        


    PLoS One

  49. PLOSCARU V, Popa-Fotea NM, Calmac L, Itu LM, et al
    Artificial intelligence and cloud based platform for fully automated PCI guidance from coronary angiography-study protocol.
    PLoS One. 2022;17:e0274296.
    PubMed         Abstract available

  50. GUO J, Givens DI, Heitmann BL
    Association between dairy consumption and cardiovascular disease events, bone fracture and all-cause mortality.
    PLoS One. 2022;17:e0271168.
    PubMed         Abstract available

  51. ROMERO R WA, Viallon M, Spaltenstein J, Petrusca L, et al
    CMRSegTools: An open-source software enabling reproducible research in segmentation of acute myocardial infarct in CMR images.
    PLoS One. 2022;17:e0274491.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  52. SAYED A, Munir M, Awad K, Koltowski L, et al
    Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies.
    Prog Cardiovasc Dis. 2022;73:88-90.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: